Paper5477337
Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
Forbes CD and 2 others. J Lab Clin Med, 1970. Cited by 231 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator. Papers, record 5477337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5477337
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement Inactivator Proteins | Major topic |
| Factor XI | Major topic |
| Factor XII | Major topic |
| Esterases | |
| Factor X | |
| Humans | |
| Time Factors |
Source PubMed
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,701,760 | C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis. | Blood | 2023 | https://conductscience.org/library/papers/36701760 | PubMed |
| 33,956,309 | Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema. | Clin Rev Allergy Immunol | 2021 | https://conductscience.org/library/papers/33956309 | PubMed |
| 26,452,350 | Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency. | Orphanet J Rare Dis | 2015 | https://conductscience.org/library/papers/26452350 | PubMed |
| 24,013,493 | Ongoing contact activation in patients with hereditary angioedema. | PLoS One | 2013 | https://conductscience.org/library/papers/24013493 | PubMed |
| 23,172,304 | P1 and P2' site mutations convert protease nexin-2 from a factor XIa inhibitor to a plasmin inhibitor. | J Biochem | 2013 | https://conductscience.org/library/papers/23172304 | PubMed |
| 21,404,067 | The many faces of the contact pathway and their role in thrombosis. | J Thromb Thrombolysis | 2011 | https://conductscience.org/library/papers/21404067 | PubMed |
| 20,647,553 | Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor. | J Biochem | 2010 | https://conductscience.org/library/papers/20647553 | PubMed |
| 20,022,081 | Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis. | Thromb Res | 2010 | https://conductscience.org/library/papers/20022081 | PubMed |
| 18,725,990 | Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18725990 | PubMed |
| 12,184,632 | Normal transcription of the C1 inhibitor gene is dependent upon a polypurine-polypyrimidine region within the promoter. | Inflammation | 2002 | https://conductscience.org/library/papers/12184632 | PubMed |
| 11,956,243 | Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. | J Clin Invest | 2002 | https://conductscience.org/library/papers/11956243 | PubMed |
| 9,926,288 | Bradykinin formation. Plasma and tissue pathways and cellular interactions. | Clin Rev Allergy Immunol | 1998 | https://conductscience.org/library/papers/9926288 | PubMed |
| 8,529,136 | A mutation unique in serine protease inhibitors (serpins) identified in a family with type II hereditary angioneurotic edema. | Mol Med | 1995 | https://conductscience.org/library/papers/8529136 | PubMed |
| 8,452,535 | Kinetic behaviour of zymogen activation processes in the presence of an inhibitor. | Biochem J | 1993 | https://conductscience.org/library/papers/8452535 | PubMed |
| 7,252,410 | Activation of the classical pathway of complement by Hageman factor fragment. | J Exp Med | 1981 | https://conductscience.org/library/papers/7252410 | PubMed |
| 7,076,850 | Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7076850 | PubMed |
| 7,040,439 | The C1 esterase inhibitor and hereditary angioedema. | J Clin Immunol | 1982 | https://conductscience.org/library/papers/7040439 | PubMed |
| 6,976,242 | Purification and characterization of two functionally distinct forms of C1 inhibitor from a patient with angioedema. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6976242 | PubMed |
| 6,902,743 | Detection of active kallikrein in induced blister fluids of hereditary angioedema patients. | J Exp Med | 1980 | https://conductscience.org/library/papers/6902743 | PubMed |
| 6,388,669 | Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli. | Blut | 1984 | https://conductscience.org/library/papers/6388669 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F12 | 2,161 | PubTator's text mining | https://conductscience.org/library/genes/2161 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/5477337
GET https://conductscience.org/api/papers/v1/5477337/cited_by?page=2